-
Authors :
Elsallab M; Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA.; Cellular Immunotherapy Program, Mass General Cancer Center, and Department of Medicine, Harvard Medical School, Boston, MA.
Subjects: Neoplasms, Second Primary*/Neoplasms, Second Primary*/Neoplasms, Second Primary*/etiology ; Neoplasms, Second Primary*/Neoplasms, Second Primary*/Neoplasms, Second Primary*/therapy ; Neoplasms, Second Primary*/Neoplasms, Second Primary*/Neoplasms, Second Primary*/epidemiology
-
Source:
Blood [Blood] 2024 May 16; Vol. 143 (20), pp. 2099-2105.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model:
Record details